ARMP
ARMP
AMEX · Biotechnology

Armata Pharmaceuticals Inc

$8.37
-0.98 (-10.48%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +108.5% upside
Low Target $10.78
Average Target $17.45
High Target $19.60
Current Price $8.37
Current
$8.37
Target
$17.45
$10.78 $17.45 avg $19.60
Scenario Analysis
Bear Case
$10.78
28.8%
Low target
Base Case
$17.45
+108.5%
Avg target
Bull Case
$19.60
+134.2%
High target
Risk/Reward
4.7x
Highly favorable
Price in Context
52-Week High
$16.34
-48.8% from high
52-Week Low
$0.90
+832.0% from low
Target vs 52W High
$17.45
+6.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%